Objective To analyze clinical feature of 30 neonates with fungal sepsis, in order to improve the level of diagnosis and treatment.Methods Totally 30 neonates with fungal sepsis and 78 premature infants with fungal sepsis were included in this study. Clinical manifestations, pathogens, laboratory findings and treatment outcomes were analyzed. The differences of laboratory parameters between fungal sepsis and bacterial sepsis were also analyzed.Results Of these cases, 25 cases(83.3%) were premature infants, and 28 cases(93.3%) had low birth weight. Risk factors included use of broad-spectrum antibiotics (29, 96.7%), tracheal intubation (18, 60.0%) and central vein catheterization (14, 46.7%). Clinical manifestations included fever, apnea and shortness of breath. Compared with premature bacterial sepsis cases, there were fewer cases with elevated procalcitonin (PCT) and more cases with thrombocytopenia in neonates with fungal sepsis (both P<0.01). G test showed that 8 out of 9 cases had positive results(88.9%). The pathogens were all Candida, including 19 strains of Candida albicans(63.3%) and 11 strains of non-Candida albicans(36.7%). For Candida albicans, all strains were susceptible to amphotericin, 14 strains were susceptible to fluconazole, while 3 strains were resistant to fluconazole and 2 strains were intermediate. All non-Candida albicans were susceptible to tested drugs. Totally 25 cases(83.3%) were cured after treatment.Conclusions The clinical manifestations of neonatal fungal sepsis were nonspecific. G test, PCT and platelet count were helpful for the diagnosis. Candida albicans were main pathogens in this study with some drug-resistant strains. Proper drug should be selected with the guidance of drug sensitive test.
Key words
sepsis /
fungus /
newborns
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Caggiano G, Lovero G, De Giglio O, et al. Candidemia in the neonatal intensive care unit: a retrospective, observational survey and analysis of literature data[J]. Biomed Res Int,2017,2017:7901763.
[2] 邵肖梅,叶鸿瑁,丘小汕. 实用新生儿学[M].4版.北京:人民卫生出版社.2011,1(4):342.
[3] 李秋平,高昕,黄捷婷,等.PNICU内早产儿真菌性败血症临床特点分析[J]. 临床儿科杂志,2010,28(6):531-534.
[4] Fridkin SK, Kaufman D, Edwards JR, et al. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004[J]. Pediatrics,2006,117(5):1680-1687.
[5] Rodriguez D, Almirante B, Park BJ, et al. Candidemia in neonatal intensive care units: Barcelona, Spain[J]. Pediatr Infect Dis J, 2006,25(3):224-229.
[6] Fu J, Ding Y, Wei B, et al. Epidemiology of Candida albicans and non-C.albicans of neonatal candidemia at a tertiary care hospital in western China[J]. BMC Infect Dis,2017,17(1):329.
[7] Hammoud MS1, Al-Taiar A, Fouad M, et al. Persistent candidemia in neonatal care units: risk factors and clinical significance[J]. Int J Infect Dis,2013,17(8):e624-e628.
[8] 张欣,茹喜芳,王颖,等.新生儿重症监护病房中新生儿真菌败血症的临床分析[J]. 北京大学学报:医学版,2017,49(5):789-793.
[9] 韩俊彦,曹云,蒋思远,等.76例新生儿侵袭性真菌感染回顾性分析:2004年至2014年[J].中华围产医学杂志,2016,19(8):586-591.
[10] Lu Q, Duan H, Yu J, et al. Are global coagulation and platelet parameters useful markers for predicting late-onset neonatal sepsis?[J]. Clin Lab, 2016,62(1-2):73-79.
[11] Pini P, Bettua C, Orsi CF, et al. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors[J]. Infection,2016,44(2):223-233.
[12] Oeser C1, Vergnano S, Naidoo R, et al. Neonatal invasive fungal infection in England 2004-2010[J]. Clin Microbiol Infect,2014,20(9):936-941.
[13] 董慧芳,徐豪,魏琛,等.新生儿真菌性败血症临床特点分析[J].中国新生儿科杂志,2013,28(3):155-158.
[14] Pemán J1, Cantón E, Linares-Sicilia MJ, et al. Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey[J]. J Clin Microbiol,2011,49(12):4158-4163.
[15] Celebi S, Hacimustafaoglu M, Koksal N, et al. Neonatal candidiasis: results of an 8 year study[J]. Pediatr Int,2012,54(3):341-349.
[16] Pandita N, Peshin C, Wasim S, et al. Profile of fungal septicemia in new born at a tertiary care hospital in North India[J]. Int J Contemp Pediatr, 2017,4(2):455-459.
[17] Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America[J]. Clin Infect Dis,2016,62(4):409-417.
[18] Hope WW, Castagnola E, Groll AH, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp[J]. Clin Microbiol Infect,2012,18(Suppl 7):38-52.
PDF(639 KB)
